RBI:VIERaiffeisen Bank International AG Analysis
Data as of 2026-06-12 - not real-time
€50.55
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Raiffeisen Bank International is trading at EUR 50.55, just below its 52‑week high of EUR 51.25 and comfortably above the calculated support of EUR 44.56. The stock sits in a bullish price environment (20‑day SMA above 50‑day SMA above 200‑day SMA) but technical momentum is weakening – the MACD histogram is negative and the signal line turned bearish, while volume has been trending down. Fundamentals remain solid: Q1 2026 operating profit rose 12% YoY to EUR 760 m, margins are stable, and the dividend yield of 3.29% is supported by a low payout ratio. However, valuation metrics flag concerns – the DCF‑derived fair value of EUR 110.9 implies the market price is overvalued by roughly 10%, and the “Extreme Greed” sentiment index suggests heightened investor optimism.
Investors should weigh the strong earnings backdrop and dividend appeal against the overvalued price, bearish short‑term technical signals, and the bank’s exposure to Eastern‑European markets.
Investors should weigh the strong earnings backdrop and dividend appeal against the overvalued price, bearish short‑term technical signals, and the bank’s exposure to Eastern‑European markets.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Bearish MACD crossover and negative histogram
- Price approaching near‑term resistance at EUR 51.25
- Decreasing volume trend indicating waning buying pressure
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Steady earnings growth and stable operating margins
- Attractive dividend yield with low payout ratio
- Valuation still above fair value but less extreme than short‑term price peak
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong cash position relative to debt and low leverage
- Strategic footprint in Central and Eastern Europe offering growth opportunities
- Dividend sustainability and potential for earnings expansion as regional economies stabilize
Key Metrics & Analysis
Financial Health
Revenue Growth-6.30%
Profit Margin12.85%
P/E Ratio16.3
ROE6.13%
ROA0.65%
P/B Ratio0.8
Op. Cash Flow€3.2B
Industry P/E16.6
Technical Analysis
TrendBullish
RSI64.6
Support€44.56
Resistance€51.25
MA 20€47.87
MA 50€45.72
MA 200€37.72
MACDBearish
VolumeDecreasing
Fear & Greed Index87.52
Valuation
Fair Value€110.91
Target Price€45.63
Upside/Downside-9.74%
GradeOvervalued
TypeBlend
Dividend Yield3.29%
Risk Assessment
Beta0.62
Volatility36.59%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.